damnacanthal has been researched along with Colorectal Neoplasms in 1 studies
damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nualsanit, T | 1 |
| Rojanapanthu, P | 1 |
| Gritsanapan, W | 1 |
| Lee, SH | 1 |
| Lawson, D | 1 |
| Baek, SJ | 1 |
1 other study available for damnacanthal and Colorectal Neoplasms
| Article | Year |
|---|---|
Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells.
Topics: Anthraquinones; Anticarcinogenic Agents; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cell Pro | 2012 |